June 21, 2012 at 10:43 AM EDT
Drop In Existing Home Sales Weighs Down Markets

A 1.5% drop in May existing home sales weighed the markets down to a lower open with the Dow losing 19 points to 12,804. Nasdaq fell 16 points to 2914.

On the upside

Genesis Healthcare will acquire Sun Healthcare Group (Nasdaq: SUNH) in a deal valued at approximately $275 million including the assumption of debt.


A Food and Drug Administration advisory panel recommended approval for Onyx Pharmaceuticals' (Nasdaq: ONXX) multiple myeloma treatment carfilzomib.


Rite Aid (NYSE: RAD) narrowed first quarter losses more than expected as same store sales rose.


On the downside


Bed Bath & Beyond (Nasdaq: BBBY) reported higher first quarter earnings but revenue fell short of expectations and the domestic merchandise retailer forecast current quarter earnings below analyst estimates.

Celgene (Nasdaq: CELG) withdrew its new indication application for expanded approval to European regulators of its multiple myeloma treatment Revlimid.

Stephens downgraded Key Energy (NYSE: KEG) from Overweight to Equal Weight and cut its price target from $16 to $11.

In the broad market, declining issues outpaced advancers by a margin of 2 to 1 on the NYSE and by nearly to 7 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 5 points 777.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here